Cargando…
Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma
OBJECTIVE: Treatment of differentiated thyroid carcinoma (DTC) includes suppression of TSH with levothyroxine therapy, which may negatively influence bone mineral density (BMD), but the effects are controversial. We aimed to evaluate the relationship between TSH-suppressive therapy and BMD in postme...
Autores principales: | de Melo, Thaís Gomes, da Assumpção, Lígia Vera Montalli, Santos, Allan de Oliveira, Zantut-Wittmann, Denise Engelbrecht |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474343/ https://www.ncbi.nlm.nih.gov/pubmed/26097507 http://dx.doi.org/10.1186/s13044-015-0019-1 |
Ejemplares similares
-
Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis
por: de Melo, Thaís Gomes, et al.
Publicado: (2018) -
Head-to-head comparison of F-18 FDG PET/CT in radioidine refractory thyroid cancer patients with elevated versus suppressed TSH levels a pilot study
por: Almeida, Ludmila Santiago, et al.
Publicado: (2020) -
Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings
por: Moura Neto, Arnaldo, et al.
Publicado: (2016) -
Usefulness of pre-thyroidectomy neutrophil–lymphocyte, platelet–lymphocyte, and monocyte–lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer
por: Riguetto, Cínthia Minatel, et al.
Publicado: (2021) -
The ages and TSH values of patients being prescribed levothyroxine
por: Jonklaas, Jacqueline, et al.
Publicado: (2020)